3261-0744 Screening compound: N-(4-ethoxyphenyl)-2-(2-phenylacetamido)-4H,5H,6H,7H,8H-cyclohepta[b]thiophene-3-carboxamide

3261-0744 Screening compound: N-(4-ethoxyphenyl)-2-(2-phenylacetamido)-4H,5H,6H,7H,8H-cyclohepta[b]thiophene-3-carboxamide
3261-0744 Screening compound: N-(4-ethoxyphenyl)-2-(2-phenylacetamido)-4H,5H,6H,7H,8H-cyclohepta[b]thiophene-3-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound 3261-0744
N-(4-ethoxyphenyl)-2-(2-phenylacetamido)-4H,5H,6H,7H,8H-cyclohepta[b]thiophene-3-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

3261-0744

Molecular Formula

C26H28N2O3S (C26 H28 N2 O3 S)

Compound Name

N-(4-ethoxyphenyl)-2-(2-phenylacetamido)-4H,5H,6H,7H,8H-cyclohepta[b]thiophene-3-carboxamide

IUPAC name

N-(4-ethoxyphenyl)-2-(2-phenylacetamido)-4H5H6H7H8H-cyclohepta[b]thiophene-3-carboxamide

SMILES

CCOc(cc1)ccc1NC(c1c(NC(Cc2ccccc2)=O)sc2c1CCCCC2)=O

InChI

InChI=1S/C26H28N2O3S/c1-2-31-20-15-13-19(14-16-20)27-25(30)24-21-11-7-4-8-12-22(21)32-26(24)28-23(29)17-18-9-5-3-6-10-18/h3,5-6,9-10,13-16H,2,4,7-8,11-12,17H2,1H3,(H,27,30)(H,28,29)

InChI Key

JKMFCZPZZSCFBC-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD01176931

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

448.59

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

5.769

Distribution Coefficient, logD

5.366

Water Solubility, LogSw

-5.43

Polar Surface Area

53.377

Acid Dissociation Constant (pKa)

7.22

Base Dissociation Constant (pKb)

-1.62

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

30.80

3261-0744 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Human Proteases Annotated Library (2868 compounds)

Human Transcription Factors Annotated Library (5098 compounds)

Protein Arginine Methyltransferases Library (27925 compounds)

Selective Target Activity Profiling Library (14702 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Cancer
  • Musculoskeletal
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Metabolic
Targets:
  • Kinases
  • Others
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with 3261-0744 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 3261-0744?
Check Price and Availability of 3261-0744, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 3261-0744 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 3261-0744
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 3261-0744
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 3261-0744 available by request